MGNX

MACROGENICS INC

MGNX·556099109·US·Common Stock·Healthcare - Biotechnology-13D/G

MGNX (MACROGENICS INC) is held by 71 institutional investors as of Q1 2026. Largest holders: RENAISSANCE TECHNOLOGIES LLC ($8.6M), MILLENNIUM MANAGEMENT LLC ($8.1M), VANGUARD CAPITAL MANAGEMENT LLC ($7.7M). Net institutional sentiment: Bullish.

71
Holders
Avg rating(13 Elite)
$91.7M
Total Value
70% (73)
Fund Consensus
44 buying - 19 selling
MGNXSmart Money Verdict
View all
Held by 71 funds
13 elite
Who's Trading
ActivistMillennium Management LLCMillennium Management LLC5.4%Jun 5, 2026
ActivistARArmistice Capital, LLC9.5%May 15, 2026
ActivistBANK OF AMERICA CORP /DE/BANK OF AMERICA CORP /DE/5.1%May 14, 2026
ActivistMillennium Management LLCMillennium Management LLC4.8%May 14, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 27, 2026
ActivistFLFrazier Life Sciences Public Fund, L.P.0.0%Feb 13, 2026
ActivistBABellevue Group AG0.0%Jan 6, 2026
ActivistWasatch Advisors LPWasatch Advisors LP3.1%Nov 12, 2025
InsiderHKHEIDEN WILLIAM KBuy $74KAug 20, 2025
InsiderHKHEIDEN WILLIAM KBuy $77KAug 19, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
3M(+1.9%)$8.6M0.0%+104.50%
28
Increased
2.8M(+41.5%)$8.1M0.0%+36.53%
37
New
2.7M$7.7M0.0%+127.89%
38
Increased
2.5M(+152.9%)$7.3M0.0%+96.45%
44
Increased
2.4M(+30.7%)$6.9M0.0%+145.86%
35
Increased
2M(+57.7%)$5.9M0.0%+100.28%
39
New
1.9M$5.4M0.1%+127.89%
37
Decreased
1.6M(-12.7%)$4.5M0.0%-74.84%
0
New
1.2M$3.5M0.0%+127.89%
37
Increased
1.2M(+0.9%)$3.4M0.0%+34.56%
27
Increased
1.1M(+39.9%)$3.1M0.0%+163.14%
35
Increased
867,249(+5.9%)$2.5M0.0%-22.39%
28
Decreased
782,618(-24.4%)$2.3M0.0%+177.96%
0
Increased
697,321(+6.4%)$2M0.0%-65.56%
28
Decreased
608,509(-51.5%)$1.8M0.0%+32.79%
0
Increased
597,442(+187.4%)$1.7M0.0%+143.03%
41
Increased
452,227(+559.8%)$1.3M0.0%+92.38%
41
Decreased
441,143(-51.0%)$1.3M0.0%+35.12%
0
Unchanged
420,000$1.2M0.0%+177.56%
0
New
340,089$982,8570.0%+127.89%
35

Showing 1-20 of 73

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used